As of 2024-07-27, the Relative Valuation of MacroGenics Inc (MGNX) is (11.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.55 USD, the upside of MacroGenics Inc based on Relative Valuation is -302.9%.
The range of the Relative Valuation is (9.73) - (11.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 31.4x | 30.8x |
| Forward P/E multiples | 26.3x - 30.8x | 30.1x |
| Fair Price | (9.73) - (11.38) | (11.26) |
| Upside | -275.4% - -305.0% | -302.9% |
| Date | P/E |
| 2024-07-26 | -15.01 |
| 2024-07-25 | -14.87 |
| 2024-07-24 | -14.20 |
| 2024-07-23 | -14.41 |
| 2024-07-22 | -14.44 |
| 2024-07-19 | -13.30 |
| 2024-07-18 | -13.57 |
| 2024-07-17 | -13.82 |
| 2024-07-16 | -14.56 |
| 2024-07-15 | -13.06 |
| 2024-07-12 | -12.71 |
| 2024-07-11 | -12.57 |
| 2024-07-10 | -11.55 |
| 2024-07-09 | -11.56 |
| 2024-07-08 | -11.44 |
| 2024-07-05 | -11.36 |
| 2024-07-03 | -11.36 |
| 2024-07-02 | -11.09 |
| 2024-07-01 | -11.63 |
| 2024-06-28 | -11.49 |
| 2024-06-27 | -11.14 |
| 2024-06-26 | -11.00 |
| 2024-06-25 | -11.60 |
| 2024-06-24 | -12.17 |
| 2024-06-21 | -11.82 |
| 2024-06-20 | -11.14 |
| 2024-06-18 | -11.14 |
| 2024-06-17 | -11.60 |
| 2024-06-14 | -12.09 |
| 2024-06-13 | -12.65 |
| 2024-06-12 | -13.49 |
| 2024-06-11 | -13.33 |
| 2024-06-10 | -12.38 |
| 2024-06-07 | -12.25 |
| 2024-06-06 | -12.63 |
| 2024-06-05 | -13.28 |
| 2024-06-04 | -11.79 |
| 2024-06-03 | -12.11 |
| 2024-05-31 | -11.06 |
| 2024-05-30 | -11.46 |
| 2024-05-29 | -11.19 |
| 2024-05-28 | -11.73 |
| 2024-05-24 | -12.30 |
| 2024-05-23 | -12.52 |
| 2024-05-22 | -12.71 |
| 2024-05-21 | -11.52 |
| 2024-05-20 | -11.52 |
| 2024-05-17 | -11.80 |
| 2024-05-16 | -13.84 |
| 2024-05-15 | -12.74 |